BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34838017)

  • 1. The costs of inappropriate referral pathways in inpatient care for three major noncommunicable diseases in Mongolia: a national registry-based analysis.
    Tuvdendorj A; Dechinkhorloo O; Dorjsuren B; Buskens E; Feenstra T
    BMC Health Serv Res; 2021 Nov; 21(1):1280. PubMed ID: 34838017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health system costs for individual and comorbid noncommunicable diseases: An analysis of publicly funded health events from New Zealand.
    Blakely T; Kvizhinadze G; Atkinson J; Dieleman J; Clarke P
    PLoS Med; 2019 Jan; 16(1):e1002716. PubMed ID: 30620729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Layering and scaling up chronic non-communicable disease care on existing HIV care systems and acute care settings in Kenya: a cost and budget impact analysis.
    Osetinsky B; Mwangi A; Pastakia S; Wilson-Barthes M; Kimetto J; Rono K; Laktabai J; Galárraga O
    J Int AIDS Soc; 2020 Jun; 23 Suppl 1(Suppl 1):e25496. PubMed ID: 32562355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individual-Level Health Care Costs Attributable to Noncommunicable Diseases: A Longitudinal Study Based on the Older Adults in China.
    Zhao SQ; Zhao LP; Xu XP; You H
    Inquiry; 2023; 60():469580231214469. PubMed ID: 38044620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The projected economic burden of non-communicable diseases attributable to overweight in Brazil by 2030.
    Giannichi B; Nilson E; Ferrari G; Rezende LFM
    Public Health; 2024 May; 230():216-222. PubMed ID: 38579649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic Burden of Irritable Bowel Syndrome with Diarrhea: Retrospective Analysis of a U.S. Commercially Insured Population.
    Buono JL; Mathur K; Averitt AJ; Andrae DA
    J Manag Care Spec Pharm; 2017 Apr; 23(4):453-460. PubMed ID: 28345443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mental health inpatient treatment expenditure trends in China, 2005-2012: evidence from Shandong.
    Xu J; Wang J; Liu R; Xing J; Su L; Yu F; Lu M
    J Ment Health Policy Econ; 2014 Dec; 17(4):173-82. PubMed ID: 25599281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost of inaction on physical inactivity to public health-care systems: a population-attributable fraction analysis.
    Santos AC; Willumsen J; Meheus F; Ilbawi A; Bull FC
    Lancet Glob Health; 2023 Jan; 11(1):e32-e39. PubMed ID: 36480931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Projected impact of population aging on non-communicable disease burden and costs in the Kingdom of Saudi Arabia, 2020-2030.
    Boettiger DC; Lin TK; Almansour M; Hamza MM; Alsukait R; Herbst CH; Altheyab N; Afghani A; Kattan F
    BMC Health Serv Res; 2023 Dec; 23(1):1381. PubMed ID: 38066590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The global impact of non-communicable diseases on healthcare spending and national income: a systematic review.
    Muka T; Imo D; Jaspers L; Colpani V; Chaker L; van der Lee SJ; Mendis S; Chowdhury R; Bramer WM; Falla A; Pazoki R; Franco OH
    Eur J Epidemiol; 2015 Apr; 30(4):251-77. PubMed ID: 25595318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.
    Blanchette CM; Gutierrez B; Ory C; Chang E; Akazawa M
    J Manag Care Pharm; 2008 Mar; 14(2):176-85. PubMed ID: 18331119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National estimates of the inpatient burden of pediatric bipolar disorder in the United States.
    Berry EA; Heaton PT; Kelton CM
    J Ment Health Policy Econ; 2011 Sep; 14(3):115-23. PubMed ID: 22116169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct costs of both inpatient and outpatient care for all type cancers: The evidence from Beijing, China.
    Yin X; Xu Y; Man X; Liu L; Jiang Y; Zhao L; Cheng W
    Cancer Med; 2019 Jun; 8(6):3250-3260. PubMed ID: 31062522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The societal cost of schizophrenia in Sweden.
    Ekman M; Granstrom O; Omerov S; Jacob J; Landen M
    J Ment Health Policy Econ; 2013 Mar; 16(1):13-25. PubMed ID: 23676412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Who is bearing the financial burden of non-communicable diseases in Mongolia?
    Dugee O; Palam E; Dorjsuren B; Mahal A
    J Glob Health; 2018 Jun; 8(1):010415. PubMed ID: 29564086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic costs of terminal care for selected non-communicable diseases from a healthcare perspective: a review of mortality records from a tertiary hospital in Nigeria.
    Olumide AO; Shmueli A; Omotade OO; Adebayo ES; Alonge TO; Ogun GO
    BMJ Open; 2021 Apr; 11(4):e044969. PubMed ID: 33895715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Minderoo-Monaco Commission on Plastics and Human Health.
    Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
    Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivering a primary-level non-communicable disease programme for Syrian refugees and the host population in Jordan: a descriptive costing study.
    Ansbro É; Garry S; Karir V; Reddy A; Jobanputra K; Fardous T; Sadique Z
    Health Policy Plan; 2020 Oct; 35(8):931-940. PubMed ID: 32621490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use and cost of hospital and community service provision for children with HIV infection at an English HIV referral centre.
    Beck EJ; Mandalia S; Griffith R; Beecham J; Walters MD; Boulton M; Miller DL
    Pharmacoeconomics; 2000 Jan; 17(1):53-69. PubMed ID: 10747765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What Is the Financial Impact of Orthopaedic Sequelae of Intravenous Drug Use on Urban Tertiary-care Centers?
    Dwivedi N; Breslin MA; McDermott A; Lin S; Vallier HA; Tornetta P
    Clin Orthop Relat Res; 2020 Oct; 478(10):2202-2212. PubMed ID: 32667752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.